ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 149 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2016. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $34,000 | -8.1% | 4,052 | 0.0% | 0.00% | – |
Q3 2015 | $37,000 | -95.2% | 4,052 | -93.7% | 0.00% | -100.0% |
Q2 2015 | $772,000 | -22.9% | 64,339 | -30.8% | 0.00% | -50.0% |
Q1 2015 | $1,001,000 | +100000.0% | 92,948 | +25647.4% | 0.00% | – |
Q3 2013 | $1,000 | 0.0% | 361 | -14.9% | 0.00% | – |
Q2 2013 | $1,000 | – | 424 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 9,709,607 | $51,946,000 | 2.80% |
MILLER VALUE PARTNERS, LLC | 4,900,721 | $26,219,000 | 1.15% |
MSD Partners, L.P. | 3,410,500 | $18,246,000 | 0.92% |
Michael & Susan Dell Foundation | 66,749 | $357,000 | 0.26% |
Glacier Peak Capital LLC | 68,043 | $364,000 | 0.21% |
Vident Investment Advisory, LLC | 114,980 | $615,000 | 0.08% |
SFMG, LLC | 62,433 | $334,000 | 0.07% |
Virtus ETF Advisers LLC | 40,359 | $216,000 | 0.06% |
Steward Partners Investment Advisory, LLC | 23,187 | $124,000 | 0.06% |
O'Dell Group, LLC | 10,142 | $54,000 | 0.05% |